Daisuke Nakamoto

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment: plain language summary of publication.

Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment: plain language summary of publication.

Journal: Therapeutic advances in gastroenterology

Published: February 17, 2026

Chronic comorbidities, concomitant medications, and treatment patterns of chronic hepatitis B patients receiving nucleos(t)ide analogue therapy: a hospital claims database study in Japan.

Chronic comorbidities, concomitant medications, and treatment patterns of chronic hepatitis B patients receiving nucleos(t)ide analogue therapy: a hospital claims database study in Japan.

Journal: BMC infectious diseases

Published: September 13, 2025

Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment.

Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment.

Journal: Journal of medical economics

Published: March 24, 2025

Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administrative claims database in Japan.

Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administrative claims database in Japan.

Journal: Journal of pharmaceutical health care and sciences

Published: February 03, 2025

Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy.

Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy.

Journal: Infectious diseases and therapy

Published: February 21, 2024

Real-world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis B.

Real-world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis B.

Journal: Journal of viral hepatitis

Published: August 17, 2023

Case fatality rate considering the lag time from the onset of COVID-19 infection to related death from 2020 to 2022 in Japan.

Case fatality rate considering the lag time from the onset of COVID-19 infection to related death from 2020 to 2022 in Japan.

Journal: IJID regions

Published: December 19, 2022

The impact of declaring the state of emergency on human mobility during COVID-19 pandemic in Japan.

The impact of declaring the state of emergency on human mobility during COVID-19 pandemic in Japan.

Journal: Clinical epidemiology and global health

Published: May 25, 2022

Novel indicator for the spread of new coronavirus disease 2019 and its association with human mobility in Japan.

Novel indicator for the spread of new coronavirus disease 2019 and its association with human mobility in Japan.

Journal: Scientific reports

Published: May 03, 2022

Preliminary investigation of aluminium fluoride complexes in aqueous solutions with capillary electrophoresis coupled with electrospray ionization mass spectrometry and with inductively coupled plasma mass spectrometry.

Preliminary investigation of aluminium fluoride complexes in aqueous solutions with capillary electrophoresis coupled with electrospray ionization mass spectrometry and with inductively coupled plasma mass spectrometry.

Journal: Rapid communications in mass spectrometry : RCM

Published: March 03, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026